SA
ABCL icon

Sanctuary Advisors’s AbCellera Biologics ABCL Stock Holding History

Sanctuary Advisors’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,359
Closed -$35.5K – 2414
2025
Q2 		$35.5K Sell
10,359
-45,373
-81% -$113K ﹤0.01% 2324
2025
Q1 		$124K Sell
55,732
-33,884
-38% -$97.2K ﹤0.01% 2091
2024
Q4 		$289K Sell
89,616
-5,500
-6% -$15.3K ﹤0.01% 2019
2024
Q3 		$263K Sell
95,116
-10,808
-10% -$29.9K ﹤0.01% 2081
2024
Q2 		$398K Buy
+105,924
New +$401K ﹤0.01% 1789

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return